CYTOVENE - CAP 250MG
CYTOVENE - CAP 250MG
Discontinued
DIN Number
02186802
Drug Class
Human
Market Date
Dec 31, 1995
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02186802
AIG Number0128037001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AB06 GANCICLOVIR
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:18.32
Health Canada Classification
ACTIVE INGREDIENTS (1)
GANCICLOVIRActive
Strength: 250 MG / CAP
Monograph: GANCICLOVIR